RICHMOND, Va., Jan. 7, 2026 /PRNewswire/ -- Alps Dx today announced its official launch as an innovative diagnostics tooling and automation company focused on improving the speed, safety, and ...
Every stage of biopharma drug development depends on what happens in the laboratory. Consequently, any one of these stages—which include target identification, lead optimization, candidate screening, ...
The complexity of antibody-drug conjugates (ADCs) demands equally sophisticated analytical strategies. Researchers must navigate fragmented workflows, manual sample preparation, and experimental ...
Screening automation bottlenecks remain a critical constraint in high-throughput screening (HTS) environments, directly impacting assay throughput, data quality, and overall drug discovery timelines.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results